Author:
Kumar Lalit,Arora Mohit Kumar,Marwah Sunil
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Reference61 articles.
1. Rosen, H., Drezner, M. Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women-UpToDate [Internet]. 2018.
2. Compston, J., Bowring, C., Cooper, A., et al. (2013). Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National osteoporosis guideline group (NOGG) update 2013. Maturitas, 75, 392–396.
3. Cosman, F., de Beur, S. J., LeBoff, M. S., et al. (2014). Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International, 25, 2359–2381.
4. Denosumab (Prolia): Treatment to increase bone mass in men with osteoporosis at high risk for fracture; or who have failed or are intolerant to other available osteoporosis therapy [Internet]. Ottawa (ON): Canadian agency for drugs and technologies in health; 2015 Oct.
5. Tsai, J., Burnett-Bowie, S., Lee, H., et al. (2017). Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study. Bone, 95, 20–25.